-
Mashup Score: 0The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis - 6 month(s) ago
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a CFTR modulator that has led to large benefits in lung function, pulmonary exacerbation rates, and respirat…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis - 9 month(s) ago
Pulmonary exacerbations (PEx) remain a major cause of morbidity and mortality in people with cystic fibrosis (PWCF). Although the combination cystic f…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Role of hyperglycemia in cystic fibrosis pulmonary exacerbations - 10 month(s) ago
Hyperglycemia could affect treatment response during cystic fibrosis (CF) exacerbations. We aimed to evaluate the prevalence and associations of hyper…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Wolters Kluwer Health - 12 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, OBGYNTweet
-
Mashup Score: 0Significance and Potential Role of Eosinophils in Non-Cystic Fibrosis Bronchiectasis - 1 year(s) ago
Bronchiectasis is a complex and heterogeneous disease with a myriad of pulmonary and extrapulmonary etiologies. Bronchiectasis has a predominantly neutrophilic inflammatory profile. However, eosinophilic inflammation has also been documented in both the airways and the systemic circulation. Various diseases (eg, asthma, allergic bronchopulmonary aspergillosis, chronic rhinosinusitis with nasal…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results - PubMed - 1 year(s) ago
CF and CRMS/CFSPID diagnoses impact maternal mental health similarly. Uncertain prognosis of CRMS/CFSPID likely contributed to the negative mental health impact. Providers should consider conducting mental health screening for every mother of a child with CRMS/CFSPID, in addition to the recommended …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report - PubMed - 1 year(s) ago
We present a patient with cystic fibrosis who used nebulized levofloxacin off-label to suppress chronic Burkholderia cenocepacia pulmonary infection. The patient was initially using tobramycin inhalation powder (TIP) off-label continuously for suppression of chronic B. cenocepacia; thi …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Contemporary cystic fibrosis incidence rates in Canada and the United States - PubMed - 1 year(s) ago
Contemporary CF incidence rates suggest CF incidence is lower than previously reported and varies widely within North America. This information is important for resource planning and for tracking how programs (e.g., genetic counselling, modulator availability etc.) may impact the incidence of CF mov …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation - PubMed - 1 year(s) ago
Progressive lung function decline was observed in people with F/RF genotypes across all assessed age groups, reinforcing the importance of early intervention and clinical monitoring to preserve lung function in all people with CF.
Source: PubMedCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 0Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis - PubMed - 1 year(s) ago
GOV: NCT03801993.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
The #effect of #elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with #cystic #fibrosis https://t.co/EMqvkiPOj7 https://t.co/xvmTUZnT9E